NASDAQ

Updated Oct 30, 8:32 AM ET

OMCL

Omnicell Inc

+$0.93 (2.59%) Thu · Closed $36.88

−$0.43 (1.16%) ☀ Pre-Market

Oct 30, 8:32 AM ET

About OMCL

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Why it moved

Latest: Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates (Zacks Investment Research)

Headlines open the publisher's site.

Sign up free to see this.

Daily pricesFundamentals

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

Votes and Bull · Bear posts, 24h. At least 5 are needed.

How do you feel about OMCL?

Latest news

News ›

Zacks Investment Research

Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates

Omnicell reported Q3 2026 earnings of $0.58 per share, beating consensus estimates of $0.42 by 38.10%, with revenues of $307.85 million slightly exceeding expectations. However, the stock has underperformed the S&P 500 by 33.7% year-to-date.

Headlines open the publisher's site.

Board · 0 threads

Open board ›

Community opinions, not advice. Posts with a target get a receipt. How receipts work ›